Mounjaro®
Starting from £179.99/mo
Start journey Learn moreTirzepatide is not listed as a recognised cause of anxiety in its UK prescribing information, and clinical trials did not identify anxiety as a common side effect. That said, some people taking tirzepatide do report feeling more anxious, and the reasons behind that are worth understanding clearly. As a prescription-only medicine, tirzepatide is started and monitored under clinical supervision — a prescriber should always be your first call if new symptoms appear.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Anxiety does not appear in the UK Summary of Product Characteristics for tirzepatide as a common, uncommon or rare adverse reaction. The SURMOUNT-1 trial, which followed over 2,500 adults with obesity for 72 weeks, reported that the most frequently occurring side effects were gastrointestinal (nausea, diarrhoea, vomiting and constipation) not mood-related. That is the strongest available signal we have from structured clinical data.
What the trials do not capture especially well is the full texture of individual experience. If you have been wondering whether Mounjaro can cause anxiety, you are often describing something real, a racing heart after a dose, a jittery feeling mid-morning, a sense of unease they did not have before. Those experiences deserve a proper explanation, not a dismissal. The NHS tirzepatide medicines page notes that dizziness and heart palpitations can occur, and it is easy to read those physical sensations as anxiety if you are not expecting them.
So the honest answer is: tirzepatide does not cause anxiety in the direct pharmacological sense, but it can produce physical symptoms that feel anxious, and those are worth unpicking one by one.
Three mechanisms deserve attention. First, hypoglycaemia. Tirzepatide slows gastric emptying and augments insulin response, so people who skip meals or eat very little (especially early in treatment) can experience a drop in blood sugar. The symptoms of mild hypoglycaemia include shakiness, sweating, a fast heartbeat and a sense of rising panic. Those overlap almost completely with what most people would describe as an anxiety episode. If the feeling arrives before a meal or a few hours after a small one, blood sugar is a more likely culprit than the medicine acting directly on mood.
Second, nausea-driven distress. Feeling persistently sick is genuinely unpleasant, and unpleasant physical experiences feed psychological unease. Nausea is the most commonly reported side effect of tirzepatide, particularly in the first few weeks on each new dose. It generally settles as your system adjusts, but while it is present, it can make everything feel harder, including your mental state.
Third, disrupted sleep. Some people find their sleep shifts during the first weeks of treatment, partly because of GI discomfort and partly because eating patterns change. Poor sleep amplifies every emotional signal, including the tendency to feel anxious. Keeping the pen in the fridge door is a habit many people develop early on, seeing it daily serves as a small reminder to also check in with how you are actually feeling, not just how the scales are moving.
Significant calorie reduction, regardless of how it is achieved, has documented effects on mood and energy. The body's stress-response systems are sensitive to energy availability. People losing weight quickly, or eating far less than they used to, can experience irritability, low mood and heightened emotional reactivity, none of which are specific to tirzepatide. There is also the psychological dimension: a lot of people starting treatment carry real anxiety about whether it will work, whether side effects will be manageable, and what happens if they have to stop. That pre-existing anxiety can surface in the early weeks and be attributed to the medicine when it was already present.
For a fuller picture of how tirzepatide works and what its recognised side effects look like, the full side-effects guide on the Mounjaro page covers the evidence in detail. If you are comparing how different medicines affect mood and wellbeing, the Mounjaro and anxiety overview goes deeper into the research context. The reasons behind anxiety-like symptoms on Mounjaro page is also worth reading alongside this one, as it addresses the mechanistic questions in more detail. And if you are wondering how tirzepatide and anxiety interact across the evidence base, that page pulls together the primary-trial data specifically.
Cost is sometimes its own source of stress during treatment. If that is a factor, the Mounjaro price comparison page sets out what private treatment typically costs and what is usually included in the price.
Most people who notice anxious feelings in the early weeks of tirzepatide find they ease as the body adapts. If anxiety-like symptoms are mild and seem connected to a specific trigger (a missed meal, a particularly nauseating dose, a poor night's sleep) monitoring them over a few days is reasonable.
Contact your prescriber if: the symptoms are persistent or worsening rather than settling; you are experiencing low mood, intrusive thoughts or any thoughts of self-harm; you are finding it difficult to function day-to-day; or you cannot identify a clear physical explanation. The MHRA's Yellow Card scheme at yellowcard.mhra.gov.uk is also available if you want to formally report a suspected side effect, that reporting genuinely feeds into post-market safety monitoring.
General NHS guidance on tirzepatide, including the full list of side effects to be aware of, is published on the NHS tirzepatide medicines page. If you are already taking tirzepatide through nume and have questions, the team is available seven days a week, reach us through the contact page. For those considering starting treatment, checking eligibility through a free consultation is the right first step; a real prescriber, not an automated system, reviews every application the same day it arrives.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.